Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.
News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.
Axcelis (Nasdaq: ACLS) reported second quarter 2026 revenue of $215.2 million, up from $194.5 million a year earlier. GAAP gross margin was 42.4% and operating margin 9.4%, yielding GAAP net income of $23.3 million and diluted EPS of $0.75. Non-GAAP diluted EPS was $1.06.
Non-GAAP operating margin was 14.7% with Adjusted EBITDA of $36.0 million. For Q3 2026, Axcelis expects revenue of about $230 million, GAAP EPS of $0.76 and non-GAAP EPS of $1.11. The company continues to incur integration costs tied to its pending merger with Veeco, expected to close in the second half of 2026.
Axcelis (NASDAQ: ACLS), a supplier of ion implantation solutions for the semiconductor industry, announced it will participate in two investor conferences in August. The company plans to attend the KBCM Technology Leadership Forum on Monday, August 10 at the Montage Deer Valley in Park City, Utah, and the 7th Annual Needham Virtual Semiconductor & SemiCap 1x1 Conference on Thursday, August 20.
Axcelis, headquartered in Beverly, Massachusetts, has provided semiconductor process solutions for over 45 years and supports the full life cycle of ion implantation systems. Investor relations and media contact details are provided for stakeholders seeking more information.
Axcelis (Nasdaq: ACLS) announced the successful evaluation closure of its Purion XEmax high energy implanter at a leading semiconductor foundry on July 28, 2026. The qualified system will be used in production of Power Management Integrated Circuits (PMICs), an emerging application requiring advanced 15 MeV implant capability.
According to Axcelis, Purion XEmax features a dual LINAC design with patented Boost Technology, enabling the industry's highest implant energies up to 15 MeV and metals reduction for next generation devices. It is part of the Purion XE Series, which offers a range of high energy ion implanters tailored for different power and high-volume applications.
Axcelis (Nasdaq: ACLS) will release its second quarter 2026 financial results before the market opens on Thursday, August 6, 2026. The company will host a conference call the same day at 8:30 a.m. ET, with live webcast and a replay available for 30 days via the Axcelis investors website.
Axcelis (NASDAQ: ACLS) plans to participate in several investor conferences in May and June 2026. Events include J.P. Morgan, B. Riley, Stifel, and Bank of America technology-focused conferences in Boston, Marina del Rey, and San Francisco, offering investors access to management and company updates.
Axcelis (Nasdaq: ACLS) reported Q1 2026 results: revenue $199.0M, GAAP gross margin 40.5%, GAAP operating margin 4.0%, GAAP EPS $0.30 and non-GAAP EPS $0.72. The company ended the quarter with about $570M cash and reiterated 2026 revenue is expected to be relatively flat vs 2025. Axcelis expects the Veeco merger to close in the second half of 2026.
Axcelis (NASDAQ: ACLS) will participate in the Advanced Semiconductor Manufacturing Conference (ASMC) on May 11–14, 2026 in Albany, New York.
Axcelis technologists will present in the technical forum on May 13 (Session 9: Equipment Optimization) and the company is sponsoring ASMC's Opening Reception and the collocated Women in Semiconductors conference on May 14. Presentations include work on MUSIC™ for SiC MOSFET implants and high-dose boron doping analysis; Julia Okvath will join a WiS panel.
Axcelis Technologies (Nasdaq: ACLS) will release first quarter 2026 financial results after market close on May 7, 2026. The company will host a conference call the same day at 5:00 p.m. ET to discuss results.
The call will be available via webcast on the Investors page at www.axcelis.com or by registering at the provided link. Webcast replays will be available for 30 days following the call.
Axcelis (NASDAQ: ACLS) announced that the Science Based Targets initiative (SBTi) approved its greenhouse gas emissions reduction targets on March 30, 2026. Axcelis committed to net-zero by 2050 and SBTi-approved interim and long-term targets for scope 1, 2 and scope 3 emissions.
Approved targets include -65.88% scope 1 & 2 by 2030 (2022 base), -51.6% scope 3 use-of-sold-products per USD value added by 2030, -90.0% scope 1 & 2 by 2050, and -97.0% scope 3 per USD value added by 2050. Axcelis will report progress in its annual sustainability report.
Axcelis (Nasdaq: ACLS) will be Diamond Sponsor of the Compound Semiconductor Asia Conference (CS Asia) held with SEMICON China 2026 on March 24–27, 2026, in Pudong, Shanghai.
President and CEO Russell Low will deliver the opening keynote on March 24, and Worldwide Applications Director Hongchen Zhao will present on March 25. Axcelis said it will showcase the next-generation Purion Power Series+ Platform to chipmakers in China.